Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Background Hemiplegia and hemiparesis are the most common deficits caused by stroke. A few small clinical trials suggest that fluoxetine enhances motor recovery but its clinical efficacy is unknown. We therefore aimed to investigate whether fluoxetine would enhance motor recovery if given soon after an ischaemic stroke to patients who have motor deficits.Methods In this double-blind, placebo-controlled trial, patients from nine stroke centres in France who had ischaemic stroke and hemiplegia or hemiparesis, had Fugl-Meyer motor scale (FMMS) scores of 55 or less, and were aged between 18 years and 85 years were eligible for inclusion. Patients were randomly assigned, using a computer random-number generator, in a 1:1 ratio to fluoxetine (20 mg once per day, orally) or placebo for 3 months starting 5-10 days after the onset of stroke. All patients had physiotherapy. The primary outcome measure was the change on the FMMS between day 0 and day 90 after the start of the study drug. Participants, carers, and physicians assessing the outcome were masked to group assignment. Analysis was of all patients for whom data were available (full analysis set). This trial is registered with ClinicalTrials.gov, number NCT00657163.Findings 118 patients were randomly assigned to fluoxetine (n=59) or placebo (n=59), and 113 were included in the analysis (57 in the fluoxetine group and 56 in the placebo group). Two patients died before day 90 and three withdrew from the study. FMMS improvement at day 90 was significantly greater in the fluoxetine group (adjusted mean 34·0 points [95% CI 29·7-38·4]) than in the placebo group (24·3 points [19·9-28·7]; p=0·003). The main adverse events in the fluoxetine and placebo groups were hyponatraemia (two [4%] vs two [4%]), transient digestive disorders including nausea, diarrhoea, and abdominal pain (14 [25%] vs six [11%]), hepatic enzyme disorders (five [9%] vs ten [18%]), psychiatric disorders (three [5%] vs four [7%]), insomnia (19 [33%] vs 20 [36%]), and partial seizure (one [<1%] vs 0).Interpretation In patients with ischaemic stroke and moderate to severe motor deficit, the early prescription of fluoxetine with physiotherapy enhanced motor recovery after 3 months. Modulation of spontaneous brain plasticity by drugs is a promising pathway for treatment of patients with ischaemic stroke and moderate to severe motor deficit.Funding Public French National Programme for Clinical Research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment with the HDAC inhibitor valproate also reactivates the plasticity related to music preference in mice through activation of plasticity in a network including the prefrontal cortex207.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [207]
In the citing paper
“Early-stage clinical investigations of acute and chronic stroke patients treated with selective serotonin reuptake inhibitors (SSRIs) have also shown favourable associations with neuroplasticity and motor recovery.12–16”
From Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors (2021) · cites this paper as [12]
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Measurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance
Fugl-Meyer, A., Jääskö, L., Leyman, I., Olsson, S., & Steglind, S. (1975) · Journal of Rehabilitation Medicine · doi:10.2340/1650197771331 · Cited by 5,564
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Gladstone, D. J., Danells, C. J., & Black, S. E. (2002) · Neurorehabilitation and Neural Repair · doi:10.1177/154596802401105171 · Cited by 2,032
Interrater Reliability of the NIH Stroke Scale
Goldstein, L. B., Bertels, C., & Davis, J. N. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520420080026 · Cited by 986
Randomisation and baseline comparisons in clinical trials
Altman, D. G., & Doré, C. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)90014-v · Cited by 508
Scheidtmann, K., Fries, W., Müller, F., & Koenig, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05966-9 · Cited by 416
Similar motor recovery of upper and lower extremities after stroke.
Duncan, P. W., Goldstein, L. B., Horner, R. D., Landsman, P. B., Samsa, G. P., & Matchar, D. B. (1994) · Stroke · doi:10.1161/01.str.25.6.1181 · Cited by 387
Amphetamine Paired With Physical Therapy Accelerates Motor Recovery After Stroke: Further Evidence
Walker-Batson, D., Smith, P., Curtis, S., Unwin, H., & Greenlee, R. (1995) · Stroke · doi:10.1161/01.str.26.12.2254 · Cited by 385
Research works printed but not linked: 1
- Schallert, 1992, Pharmacologic and anatomic considerations in recovery of function, Phys Med Rehabil, 6, 375
Cited by
Winstein, C. J., Stein, J., Arena, R., Bates, B., Cherney, L. R., Cramer, S. C., Deruyter, F., Eng, J. J., Fisher, B., Harvey, R. L., et al. (2016) · Stroke · doi:10.1161/str.0000000000000098 · Cited by 3,293
Campbell, B. C. V., De Silva, D. A., Macleod, M. R., Coutts, S. B., Schwamm, L. H., Davis, S. M., & Donnan, G. A. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0118-8 · Cited by 1,750
Greenberg, S. M., Ziai, W. C., Cordonnier, C., Dowlatshahi, D., Francis, B., Goldstein, J. N., Hemphill, J. C., Johnson, R., Keigher, K. M., Mack, W. J., et al. (2022) · Stroke · doi:10.1161/str.0000000000000407 · Cited by 1,639
Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex
McEwen, B. S., Nasca, C., & Gray, J. D. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.171 · Cited by 1,574
What Is the Evidence for Physical Therapy Poststroke? A Systematic Review and Meta-Analysis
Veerbeek, J. M., van Wegen, E., van Peppen, R., van der Wees, P. J., Hendriks, E., Rietberg, M., & Kwakkel, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087987 · Cited by 1,203
Metadata
- Authors
- Chollet, F., Tardy, J., Albucher, J.-F., Thalamas, C., Berard, E., Lamy, C., Bejot, Y., Deltour, S., Jaillard, A., Niclot, P., Guillon, B., Moulin, T., Marque, P., Pariente, J., Arnaud, C., & Loubinoux, I.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Centre Hospitalier Sainte-Anne (FR)
- Pitié-Salpêtrière Hospital (FR)
- Hôpital Albert Michallon (FR)
- Hôpital NOVO (FR)
- Centre Hospitalier Universitaire de Besançon (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Corresponding author
- Chollet, François
- ORCID
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 10
- Issue
- 2
- Pages
- 123-130
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2108025392
- Cited by
- 925
- References
- 34
- Citations by year
- 2026: 23 · 2025: 24 · 2024: 44 · 2023: 37 · 2022: 41 · 2021: 81 · 2020: 80 · 2019: 79 · 2018: 54 · 2017: 84 · 2016: 57 · 2015: 67 · 2014: 67 · 2013: 79 · 2012: 63
- FWCI
- 81.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Keywords
- fluoxetine, ischemic stroke, motor recovery, hemiplegia, hemiparesis, antidepressant treatment, stroke rehabilitation, physiotherapy, hyponatremia, adverse events, focal seizures, insomnia, mental illness, stroke recurrence
- MeSH terms
- Acute Disease, Aged, Double-Blind Method, Female, Fluoxetine, Humans, Male, Middle Aged, Motor Skills, Prospective Studies, Treatment Outcome, Recovery of Function, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s1474-4422(10)70314-8
- The paper
- Chollet, F., Tardy, J., Albucher, J.-F., Thalamas, C., Berard, E., Lamy, C., Bejot, Y., Deltour, S., Jaillard, A., Niclot, P., Guillon, B., Moulin, T., Marque, P., Pariente, J., Arnaud, C., & Loubinoux, I. (2011). Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(10)70314-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.